MDM2 suppresses p73 function without promoting p73 degradation.

The newly identified p53 homolog p73 can mimic the transcriptional activation function of p53. We investigated whether p73, like p53, participates in an autoregulatory feedback loop with MDM2. p73 bound to MDM2 both in vivo and in vitro. Wild-type but not mutant MDM2, expressed in human p53 null osteosarcoma Saos-2 ...
cells, inhibited p73- and p53-dependent transcription driven by the MDM2 promoter-derived p53RE motif as measured in transient-transfection and chloramphenicol acetyltransferase assays and also inhibited p73-induced apoptosis in p53-null human lung adenocarcinoma H1299 cells. MDM2 did not promote the degradation of p73 but instead disrupted the interaction of p73, but not of p53, with p300/CBP by competing with p73 for binding to the p300/CBP N terminus. Both p73alpha and p73beta stimulated the expression of the endogenous MDM2 protein. Hence, MDM2 is transcriptionally activated by p73 and, in turn, negatively regulates the function of this activator through a mechanism distinct from that used for p53 inactivation.
Mesh Terms:
Apoptosis, DNA-Binding Proteins, Feedback, Fluorescent Antibody Technique, Gene Expression Regulation, Genes, Reporter, Genes, Tumor Suppressor, Humans, Mutation, Nuclear Proteins, Protein Binding, Proto-Oncogene Proteins, Proto-Oncogene Proteins c-mdm2, Recombinant Proteins, Trans-Activators, Transcription, Genetic, Transcriptional Activation, Tumor Cells, Cultured, Tumor Suppressor Protein p53, Tumor Suppressor Proteins
Mol. Cell. Biol.
Date: May. 01, 1999
Download Curated Data For This Publication
5783
Switch View:
  • Interactions 2